STDS Trademark

Trademark Overview

On Monday, April 9, 2001, a trademark application was filed for STDS with the United States Patent and Trademark Office. The USPTO has given the STDS trademark a serial number of 78057408. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 13, 2012. This trademark is owned by Andrx Pharmaceuticals, Inc.. The STDS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Product research and development in the field of pharmaceutical formulation technologies for controlled release or delivery of pharmaceuticals

General Information

Serial Number78057408
Word MarkSTDS
Filing DateMonday, April 9, 2001
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 13, 2012
Registration Number2993008
Registration DateTuesday, September 6, 2005
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 11, 2003

Trademark Statements

Goods and ServicesProduct research and development in the field of pharmaceutical formulation technologies for controlled release or delivery of pharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 13, 2012
Primary Code042
First Use Anywhere DateSaturday, July 27, 2002
First Use In Commerce DateSaturday, July 27, 2002

Trademark Owner History

Party NameAndrx Pharmaceuticals, LLC.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressDavie, FL 33314
Party NameAndrx Pharmaceuticals, LLC.
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressDavie, FL 33314
Party NameAndrx Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDavie, FL 33314
Party NameAndrx Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDavie, FL 33314

Trademark Events

Event DateEvent Description
Friday, April 13, 2012CANCELLED SEC. 8 (6-YR)
Wednesday, April 9, 2008ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, January 25, 2006ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 25, 2006TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 6, 2005REGISTERED-PRINCIPAL REGISTER
Tuesday, July 26, 2005LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, May 23, 2005ASSIGNED TO LIE
Saturday, May 14, 2005ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, May 13, 2005STATEMENT OF USE PROCESSING COMPLETE
Friday, April 29, 2005USE AMENDMENT FILED
Friday, April 29, 2005TEAS STATEMENT OF USE RECEIVED
Wednesday, April 6, 2005EXTENSION 4 GRANTED
Wednesday, April 6, 2005EXTENSION 4 FILED
Wednesday, April 6, 2005TEAS EXTENSION RECEIVED
Thursday, October 21, 2004EXTENSION 3 GRANTED
Wednesday, October 6, 2004EXTENSION 3 FILED
Wednesday, October 6, 2004TEAS EXTENSION RECEIVED
Monday, May 10, 2004EXTENSION 2 GRANTED
Monday, May 3, 2004EXTENSION 2 FILED
Thursday, May 6, 2004CASE FILE IN TICRS
Monday, May 3, 2004TEAS EXTENSION RECEIVED
Monday, May 3, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 14, 2003EXTENSION 1 GRANTED
Thursday, November 6, 2003EXTENSION 1 FILED
Thursday, November 6, 2003TEAS EXTENSION RECEIVED
Tuesday, May 6, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 11, 2003PUBLISHED FOR OPPOSITION
Wednesday, January 22, 2003NOTICE OF PUBLICATION
Tuesday, December 17, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 11, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 22, 2002ASSIGNED TO EXAMINER
Friday, October 11, 2002TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 11, 2002NON-FINAL ACTION MAILED
Monday, February 25, 2002Sec. 1(B) CLAIM ADDED
Monday, February 25, 2002SEC. 1(A) CLAIM DELETED
Friday, February 22, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 25, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 22, 2001NON-FINAL ACTION MAILED
Wednesday, August 1, 2001ASSIGNED TO EXAMINER

Related Keywords

stds controlled release delivery pharmaceuticals technologies formulation research development field pharmaceutical